The discovery of rivaroxaban: translating preclinical assessments into clinical practice.
about
Rivaroxaban and stroke prevention in patients with atrial fibrillation: new evidence.Efficacy and safety of rivaroxaban in real-life patients with atrial fibrillation.Rivaroxaban for the treatment and prevention of thromboembolic disease.Rivaroxaban in patients with atrial fibrillation: from ROCKET AF to everyday practice.Rivaroxaban Induces Mucosal Healing in a Rat Model of Trinitrobenzene Sulfonic Acid-Induced Colitis.Discovery methods of coagulation-inhibiting drugs.
P2860
The discovery of rivaroxaban: translating preclinical assessments into clinical practice.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
The discovery of rivaroxaban: translating preclinical assessments into clinical practice.
@en
type
label
The discovery of rivaroxaban: translating preclinical assessments into clinical practice.
@en
prefLabel
The discovery of rivaroxaban: translating preclinical assessments into clinical practice.
@en
P2860
P356
P1476
The discovery of rivaroxaban: translating preclinical assessments into clinical practice
@en
P2093
Dagmar Kubitza
Elisabeth Perzborn
P2860
P356
10.3389/FPHAR.2013.00145
P577
2013-11-25T00:00:00Z